GB201517527D0 - GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers - Google Patents
GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockersInfo
- Publication number
- GB201517527D0 GB201517527D0 GBGB1517527.6A GB201517527A GB201517527D0 GB 201517527 D0 GB201517527 D0 GB 201517527D0 GB 201517527 A GB201517527 A GB 201517527A GB 201517527 D0 GB201517527 D0 GB 201517527D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- gdf
- predict
- treatment
- immune checkpoint
- clinical outcome
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (13)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1517527.6A GB201517527D0 (en) | 2015-10-02 | 2015-10-02 | GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
PCT/EP2016/073519 WO2017055612A1 (en) | 2015-10-02 | 2016-09-30 | Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
CA3000290A CA3000290C (en) | 2015-10-02 | 2016-09-30 | Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
FIEP16779036.9T FI3356827T3 (en) | 2015-10-02 | 2016-09-30 | Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
EP23206060.8A EP4321866A3 (en) | 2015-10-02 | 2016-09-30 | Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
US15/765,174 US11262360B2 (en) | 2015-10-02 | 2016-09-30 | GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
ES16779036T ES2968226T3 (en) | 2015-10-02 | 2016-09-30 | GDF-15 as a diagnostic marker to predict the clinical outcome of treatment with immune checkpoint blockers |
EP16779036.9A EP3356827B1 (en) | 2015-10-02 | 2016-09-30 | Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
JP2018516740A JP6858181B2 (en) | 2015-10-02 | 2016-09-30 | GDF-15 as a diagnostic marker for predicting clinical outcomes of treatment with immune checkpoint blockers |
KR1020187012419A KR102621034B1 (en) | 2015-10-02 | 2016-09-30 | GDF-15 as a diagnostic marker to predict the clinical course of treatment with immune checkpoint blockers |
DK16779036.9T DK3356827T3 (en) | 2015-10-02 | 2016-09-30 | GDF-15 AS A DIAGNOSTIC MARKER FOR PREDICTING THE CLINICAL OUTCOME OF TREATMENT WITH IMMUNE CHECKPOINT BLOCKERS |
AU2016333538A AU2016333538B2 (en) | 2015-10-02 | 2016-09-30 | GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
US17/580,245 US20220242942A1 (en) | 2015-10-02 | 2022-01-20 | Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB1517527.6A GB201517527D0 (en) | 2015-10-02 | 2015-10-02 | GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
Publications (1)
Publication Number | Publication Date |
---|---|
GB201517527D0 true GB201517527D0 (en) | 2015-11-18 |
Family
ID=54606072
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB1517527.6A Ceased GB201517527D0 (en) | 2015-10-02 | 2015-10-02 | GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB201517527D0 (en) |
-
2015
- 2015-10-02 GB GBGB1517527.6A patent/GB201517527D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
FI3356827T3 (en) | Gdf-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers | |
HK1216927A1 (en) | Determining human stimuli at computing devices | |
IL262522B (en) | Therapeutic neuregulin peptides for the treatment or prophylaxis of heart failure | |
EP2960362A4 (en) | Shoes upper part knitting method | |
IL240769A0 (en) | Human antibodies to grem 1 | |
HK1218298A1 (en) | Cyclic polypeptides for the treatment of heart failure | |
IL244042B (en) | Method for the treatment of fibrotic disease | |
PL3102949T3 (en) | Diagnosis of a neurological disease | |
IL255046A0 (en) | Biosequence-based approach to analyzing binaries | |
HK1219653A1 (en) | Methods for the treatment of mitochondrial disease | |
IL248592A0 (en) | Treatment of crohn's disease with delayed-release 6-mercaptopurine | |
HK1232290A1 (en) | Novel assay to detect human periostin | |
EP2990010A4 (en) | Artificial blood vessel | |
GB201408621D0 (en) | Apparatus for traking the position of at least one person walking about a structure | |
GB2540970B (en) | Executing Groups of Instructions Atomically | |
EP3515428C0 (en) | Method to alleviate the symptoms of pms | |
EP3548095C0 (en) | Methods of mouse clinical trial | |
GB201517527D0 (en) | GDF-15 as a diagnosis marker to predict the clinical outcome of a treatment with immune checkpoint blockers | |
GB201607800D0 (en) | GDF-15 as a diagnostic marker to predict the clinical outcome of a treatment with immune checkpoint blockers | |
GB201410144D0 (en) | Blood clot risk reducing footwear | |
GB201410118D0 (en) | Early diagnosis of leptospire | |
HK1244444A1 (en) | Assay to detect human dpp-4 | |
GB201519365D0 (en) | Improvements relating to human body measurement | |
GB201522938D0 (en) | A combination of traditional chinese medicines for the treatment of stomachache | |
GB201419896D0 (en) | Improvements relating to human body measurement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |